PHC Holdings Corp. 6523

Investing.com -- PHC Holdings (TYO:6523) shares surged to a near four-year high, after the Japanese healthcare company confirmed it had received an initial takeover proposal from Toho Holdings.

BASEL, Switzerland, August 06, 2026--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TYO 6523), has launched its fifth annual This Is Diabetes Art & Photography Competition in support of World Diabetes Day 2026.

LEEDS, United Kingdom, August 05, 2026--A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the UK's National Health Service.

PORTSMOUTH, N.H. & KALAMAZOO, Mich., July 28, 2026--Epredia, a global leader in precision cancer diagnostics solutions, has announced an agreement with Canada-based manufacturer Lab Improvements to bring intelligent archiving for tissue samples to U.S. pathology labs. Epredia will add two automated archiving solutions by Lab Improvements, BlockTracker and SlideTracker, to its product portfolio in the U.S., enabling more labs to access comprehensive traceability for the life of every pathology sa

BASEL, Switzerland, June 01, 2026--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of CONTOUR®COMFORT pen needles, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience.

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions WorldwidePORTSMOUTH, N.H. and KALAMAZOO, Mich., May 07, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market, today announced that Epredia, a global leader in precision cancer diagnostics solutions and a subsidi